This insight might be useful for the design of aggregation inhibitors that improve upon the weak aggregation-inhibiting properties of rat amylin: computational screening of fiber-binding compounds could reveal small organic molecules or peptide-mimetics that stabilize the β-sheet regions reducing in this way amylin toxicity in type-2 diabetes. The gene discussed is IAPP; the disease is type 2 diabetes mellitus.